Utang jangka dawa marang ekuitas Johnson & Johnson Co. (JNJ)

Johnson & Johnson (JNJ) generates revenue through the commercialization of innovative pharmaceuticals and the development of sophisticated surgical instrumentation. Following the spin-off of its consumer health division, the holding company pivoted toward expansion by acquiring promising biomedical startups. The current figure stands at 0.41. This chart of stock quotes completes the profile of a conservative business that relies on strict ethical principles and ensures high stability for its workforce.

As a global leader in pharmaceuticals and medical technology, Johnson & Johnson (JNJ) leverages a diversified portfolio to minimize systemic risks. This long-term debt financial leverage metric compares liabilities with maturities exceeding one year against net assets, allowing investors to assess the capital structure's reliance on borrowed funds and determine the business's actual margin of safety during scaling.